Table 3.
Numbers of patients receiving Gaucher disease specific treatments
| Member association’s country | Imiglucerase | Velaglucerase alfa | Eliglustat tartrate | Miglustat | Taliglucerase alfa | Other* | Total |
|---|---|---|---|---|---|---|---|
| Austria | 11 | 5 | 4 | 1 | 21 | ||
| Belgium | 22 | 3 | 1 | 26 | |||
| Bosnia & Herzegovina | 3 | 1 | 0 | 4 | |||
| Bulgaria | 13 | 13 | |||||
| Canada | 60 | 13 | 13 | 11 | 2 | 99 | |
| Czech Republic | 21 | 6 | 2 | 29 | |||
| Denmark | 11 | 5 | 16 | ||||
| Estonia | 3 | 3 | |||||
| Finland | 6 | 2 | 1 | 9 | |||
| Germany | 230 | 61 | 9 | 1 | 301 | ||
| Greece | 57 | 6 | 3 | 6 | 72 | ||
| Israel | 80 | 160 | 10 | 60 | 5 | 315 | |
| Italy | 113 | 35 | 10 | 158 | |||
| Jordan | 16 | 1 | 17 | ||||
| Latvia | 2 | 2 | |||||
| Lithuania | 8 | 8 | |||||
| Macedonia | 4 | 4 | |||||
| Norway | 5 | 8 | 13 | ||||
| Romania | 55 | 1 | 2 | 58 | |||
| Russia | 258 | 6 | 40 | 304 | |||
| Serbia | 13 | 6 | 8 | 27 | |||
| Slovenia | 13 | 4 | 17 | ||||
| South Africa | 48 | 3 | 5 | 56 | |||
| Spain | 80 | 50 | 4 | 30 | 5 | 169 | |
| Sweden | 37 | 6 | 3 | 46 | |||
| UK & RoI | 112 | 93 | 2 | 7 | 5 | 1 | 220 |
| Ukraine | 36 | 36 | |||||
| TOTAL | 1317 | 466 | 93 | 75 | 86 | 6 | 2043 |
| % of total | 64 | 23 | 5 | 4 | 4 | 0.3 |
*Other treatments: Israel: oral enzyme replacement therapy (PRX-112) in clinical trial [Protalix, Carmiel, Israel], UK & RoI: 1 alglucerase.